US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,379.06

+4.600.33%

Number of Gainers:9

Number of Losers:9

Number of Flat:1

PE:- -

High:1,392.07

Open:1,378.91

Low:1,377.90

Close:1,374.47

Loading ...

Abbott Exec Says Co Expects Headwind of Around $700 Million on 2025 Sales Growth in Diagnostics - Conf Call

THOMSON REUTERS

Abbott down 5% at $125.40 after Q2 results, narrowed FY25 outlook

BioNTech SE Announces Resignation of Chief Strategy Officer Ryan Richardson Effective September 2025

Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors

Johnson & Johnson's TAR-200 Receives U.S. FDA Priority Review for High-Risk Bladder Cancer Treatment

Johnson & Johnson Receives U.S. FDA Priority Review for Tar-200 Nda in High-Risk Non-Muscle Invasive Bladder Cancer

THOMSON REUTERS

Moderna (MRNA) Receives a Sell from J.P. Morgan

BUZZ-Street View: Johnson & Johnson's strength in product pipeline to drive growth

Abbott Laboratories Shares Down 3% Premarket After Q2 Results

THOMSON REUTERS

Abbott beats quarterly profit estimates on medical devices demand

Abbott Q2 REV $11.1 Bln VS Ibes Estimate $11.07 Bln

THOMSON REUTERS

Abbott: Plans to Build a New Manufacturing Facility in the U.S. State of Georgia by 2028

THOMSON REUTERS

Abbott Q2 EPS USD 1.01

THOMSON REUTERS

Abbott Q2 Adjusted EPS USD 1.26 VS. Ibes Estimate USD 1.25

THOMSON REUTERS

Abbott: Outlook FY2025 Organic Sales Growth, Excluding Covid-19 Testing Related Sales, to Be 7.5% to 8.0%

THOMSON REUTERS

Abbott Reports Second-Quarter 2025 Results

THOMSON REUTERS

Bristol, Pfizer to sell blood thinner Eliquis directly to patients

Bristol-Myers Squibb Co - Eligible U.S. Patients Can Purchase Eliquis Directly From September 8

THOMSON REUTERS

Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (Apixaban) Option

THOMSON REUTERS

J&J : Leerink Partners Raises Target Price to $171 From $153

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1379.0648,"timestamp":1752868799999,"preClose":1374.4666,"halted":0,"volume":95651171,"delay":0,"changeRate":0.003345,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":4.598267,"latestTime":"07-18 16:00:00 EDT","open":1378.9058,"high":1392.0709,"low":1377.9001,"amount":6183943014.250345,"amplitude":0.01031,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1752883200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.73069,"peRate":21.631713,"turnoverRate":0.006249,"increases":9,"decrements":9,"flats":1,"marketCap":1137445199268.5,"floatMarketCap":1116746960372.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1392.0709,"amplitude":0.01031,"preClose":1374.4666,"low":1377.9001,"pbRate":"3.73069","latestPrice":1379.0648,"volume":95651171,"delay":0,"open":1378.9058,"prevYearClose":1274.8187,"prevWeekClose":1397.679,"prevMonthClose":1377.5769,"prevQuarterClose":1377.5769,"fiveDayClose":1397.679,"twentyDayClose":1359.4229,"sixtyDayClose":1350.4775,"secType":"PLATE","market":"US","turnoverRate":0.006249,"peRate":21.631713,"marketCap":1137445199268.5,"floatMarketCap":1116746960372.5,"timestamp":1752868799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":9,"down":9,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552481753","title":"Abbott Exec Says Co Expects Headwind of Around $700 Million on 2025 Sales Growth in Diagnostics - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2552481753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552481753?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:09","pubTimestamp":1752757797,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE13X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237957902.USD","IE0009355771.USD","LU1721429741.USD","LU2468319806.SGD","SG9999002232.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU2237957811.SGD","LU0170899867.USD","LU2089984988.USD","BK4082","LU1989763690.USD","LU1914381329.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0122379950.USD","LU1061106388.HKD","BK4585","BK4581","LU0868494617.USD","LU0266013472.USD","LU1023059063.AUD","SG9999004303.SGD","LU0234572021.USD","LU1989763427.SGD","BK4592","LU2133065610.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","BK4533","LU1691799644.USD","SG9999002224.SGD","BK4568","IE00B4R5TH58.HKD","BK4566","ABT","BK4588","LU1721429402.USD","SGXZ23171101.USD","BK4504","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2552390481","title":"Abbott down 5% at $125.40 after Q2 results, narrowed FY25 outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2552390481","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552390481?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:30","pubTimestamp":1752755433,"startTime":"0","endTime":"0","summary":"Shares of Abbott (ABT) are down about 5% or $6.34 at $125.41, a three-month low, after reporting Q2 earnings and narrowing its guidance. Published ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbott-down-5-at-125-40-after-q2-results-narrowed-fy25-outlook-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbott-down-5-at-125-40-after-q2-results-narrowed-fy25-outlook-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1721429741.USD","SG9999002224.SGD","BK4082","IE0002141913.USD","SGXZ23171101.USD","IE0009355771.USD","LU2237957811.SGD","LU0266013472.USD","LU1691799644.USD","BK4504","LU1057294990.SGD","LU0868494617.USD","LU1989763690.USD","BK4566","BK4533","SG9999004303.SGD","LU1061106388.HKD","BK4568","BK4585","BK4581","LU2112291526.USD","LU0170899867.USD","ABT","IE00B2B36J28.USD","BK4592","LU2468319806.SGD","LU1989763427.SGD","LU2237957902.USD","SG9999002232.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","LU1721429402.USD","LU2133065610.SGD","LU1023059063.AUD","LU2089984988.USD","BK4588","IE00BFTCPJ56.SGD","LU0122379950.USD","IE00B4R5TH58.HKD","LU1914381329.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2552489746","title":"BioNTech SE Announces Resignation of Chief Strategy Officer Ryan Richardson Effective September 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489746","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489746?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:30","pubTimestamp":1752755424,"startTime":"0","endTime":"0","summary":"BioNTech SE has announced that Ryan Richardson will step down from his roles as Chief Strategy Officer and Board Member, effective September 30, 2025. The company is in the process of transferring his responsibilities to other board members to ensure a smooth transition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via GlobeNewswire  on July 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL1Ylhcg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4112","BK4535","BK4548","BNTX","LU2210150020.SGD","BK4568","IE00BGHQF748.EUR","LU2095319765.USD","BK4551","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","NDAQ","BK4588","LU2210149790.SGD","BK4139"],"gpt_icon":0},{"id":"2552489414","title":"Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489414","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489414?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:15","pubTimestamp":1752754500,"startTime":"0","endTime":"0","summary":"Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90%Underscores Royalty Pharma’s commitment to enhanced corporate g","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/17/3117185/0/en/Royalty-Pharma-Appoints-Carole-Ho-and-Elizabeth-Weatherman-to-the-Company-s-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU0985481810.HKD","SG9999013999.USD","LU1894683348.USD","LU1883839398.USD","LU1894683264.USD","BK4592","SG9999002232.USD","SG9999001176.SGD","SG9999011175.SGD","PFE","LU0234572021.USD","SG9999002224.SGD","BK4534","LU1057294990.SGD","IE0002270589.USD","LU1066051498.USD","SG9999001176.USD","LU0058720904.USD","LU0122379950.USD","SGXZ57979304.SGD","LU0456855351.SGD","LU0321505439.SGD","LU0321505868.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4581","IE00B19Z3B42.SGD","LU0225771236.USD","BK4533","LU1066053197.SGD","IE00BLSP4239.USD","BK4550","BK4585","SG9999003800.SGD","LU0225284248.USD","LU0306807586.USD","LU0170899867.USD","IE00BBT3K403.USD","LU0289739699.SGD","LU1023059063.AUD","BK4588","BK4007","BK4599","BK4568","LU0868494617.USD","LU0306806265.USD"],"gpt_icon":0},{"id":"2552489398","title":"Johnson & Johnson's TAR-200 Receives U.S. FDA Priority Review for High-Risk Bladder Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489398","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489398?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:01","pubTimestamp":1752753671,"startTime":"0","endTime":"0","summary":"Johnson & Johnson has announced that the U.S. Food and Drug Administration  has granted Priority Review to their New Drug Application  for TAR-200, an innovative intravesical gemcitabine releasing system designed for the treatment of high-risk non-muscle invasive bladder cancer  that is unresponsive to Bacillus Calmette-Guérin  therapy. The NDA is supported by promising results from the Phase 2b SunRISe-1 study, which showed an 82.4% complete response rate, with more than half of the patients remaining cancer-free for at least a year. TAR-200 represents a significant advancement in drug delivery for bladder cancer, being the first intravesical drug releasing system to provide sustained treatment directly into the bladder. This regulatory milestone highlights Johnson & Johnson's commitment to transforming treatment options for bladder cancer, offering new hope for patients with limited alternatives.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL1vdDCs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","BK4568","SG9999001440.SGD","LU0882574055.USD","LU1221951129.SGD","BK4533","LU1674673428.USD","LU1280957306.USD","LU1221951046.USD","LU1162221912.USD","LU1732799900.SGD","LU0640476718.USD","LU0345769128.USD","SG9999002232.USD","LU2468319806.SGD","IE0002141913.USD","LU2129689431.USD","BK4550","LU1914381329.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE000M9KFDE8.USD","LU2129689514.USD","IE00BFTCPJ56.SGD","LU0098860793.USD","LU0792757196.USD","LU1059921491.USD","LU1778281490.HKD","LU1023059063.AUD","LU1261432733.SGD","BK4532","JNJ","LU1894683264.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU2430703251.USD","LU1066051225.USD","LU1732800096.USD","BK4504","IE00BLSP4452.SGD","LU0345770993.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0345769631.USD","LU2089984988.USD","IE00B7SZLL34.SGD","LU1935042991.SGD","IE00BVYPNW00.USD"],"gpt_icon":0},{"id":"2552017486","title":"Johnson & Johnson Receives U.S. FDA Priority Review for Tar-200 Nda in High-Risk Non-Muscle Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2552017486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552017486?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:00","pubTimestamp":1752753606,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUA5XDD3D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066051498.USD","LU0289739699.SGD","IE000M9KFDE8.USD","BK4592","LU1267930813.SGD","LU1674673691.USD","IE0002270589.USD","LU2089984988.USD","LU2505996681.GBP","LU1244550577.SGD","LU1244550221.USD","LU0792757196.USD","IE0002141913.USD","BK4568","IE00B42XCP33.USD","IE00BSNM7G36.USD","LU1059921491.USD","LU1674673428.USD","LU2133065610.SGD","IE00BFXG1179.USD","LU1718418525.SGD","LU0985320562.USD","LU0882574055.USD","LU1430594728.SGD","LU1032955483.USD","BK4550","IE00B19Z3B42.SGD","LU0203345920.USD","LU1061106388.HKD","LU1066053197.SGD","LU2129689605.HKD","LU1057294990.SGD","LU1280957306.USD","LU1162221912.USD","LU0058720904.USD","IE00B19Z3581.USD","IE00B3T34201.USD","LU1221951129.SGD","JNJ","LU0122379950.USD","LU1244550494.USD","LU1506573853.SGD","SG9999002232.USD","IE00BGHQF631.EUR","LU0098860793.USD","IE00BVYPNV92.GBP","BK4588","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU1935042991.SGD"],"gpt_icon":0},{"id":"2552489814","title":"Moderna (MRNA) Receives a Sell from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489814?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:57","pubTimestamp":1752753424,"startTime":"0","endTime":"0","summary":"In a report released today, Jessica Fye from J.P. Morgan maintained a Sell rating on Moderna, with a price target of $26.00. The company’s shares c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-sell-from-j-p-morgan-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-sell-from-j-p-morgan-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BK4551","BK4568","LU0225283273.USD","BK4139","LU1989772840.SGD","LU1989772923.USD","LU2023251221.USD","LU0267386448.USD","BK4533","LU0314104364.USD","LU0158827781.USD","BK4501","LU1162221912.USD","LU1720051108.HKD","LU1732799900.SGD","LU0795875086.SGD","LU0006306889.USD","LU2111349929.HKD","LU1074936037.SGD","LU2089284900.SGD","BK4548","LU0320765646.SGD","MRNA","LU0098860793.USD","BK4585","LU2357305700.SGD","LU2347655156.SGD","BK4588","LU1720051017.SGD","LU2028103732.USD","BK4581","LU0912757837.SGD","BK4532","LU1363072403.SGD","LU0158827948.USD","LU0106831901.USD","LU2089283258.USD","BK4516","IE00BKVL7J92.USD","LU0971096721.USD","LU1732800096.USD","LU0795875169.SGD","BK4534","LU2133065610.SGD","LU1548497426.USD","LU1668664300.SGD","LU2271345857.HKD","LU0106261372.USD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2552486419","title":"BUZZ-Street View: Johnson & Johnson's strength in product pipeline to drive growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486419","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486419?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:41","pubTimestamp":1752752512,"startTime":"0","endTime":"0","summary":"BUZZ-Street View: Johnson & Johnson's strength in product pipeline to drive growth** Johnson & Johnson JNJ.N halved its expectations for costs this year related to new tariffs and raised full-year sal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4N3TE0LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU2065731478.USD","IE00B7SZLL34.SGD","LU0345770308.USD","LU0792757196.USD","IE0002141913.USD","LU2602419157.SGD","BK4112","BK4598","LU0234570918.USD","LU1261432733.SGD","LU0289739699.SGD","LU1718418525.SGD","LU1196500208.SGD","LU1894683264.USD","LU1162221912.USD","BK4581","LU1280957306.USD","LU1732800096.USD","LU1032955483.USD","IE00B42XCP33.USD","IE00BN8TJ469.HKD","IE0009355771.USD","IE00BLSP4452.SGD","IE0034235303.USD","BK4007","LU1244550221.USD","LU1674673691.USD","MORN","LU0466842654.USD","IE00BDGV0183.EUR","LU1267930813.SGD","JNJ","BK4568","LU1894683348.USD","BK4550","LU1585245621.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","SG9999002224.SGD","LU2430703251.USD","SG9999002232.USD","LU0345770993.USD","SG9999001440.SGD","LU2347655156.SGD","LU1914381329.SGD","LU1059921491.USD","BK4504","BK4592","BK4534"],"gpt_icon":0},{"id":"2552486611","title":"Abbott Laboratories Shares Down 3% Premarket After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486611","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486611?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:34","pubTimestamp":1752752090,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4N3TE0WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","LU1721429741.USD","BK4581","LU0122379950.USD","LU2237957902.USD","SG9999002224.SGD","LU1061106388.HKD","SGXZ23171101.USD","IE00BJT1NW94.SGD","LU2133065610.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","BK4082","IE0002141913.USD","LU0266013472.USD","BK4566","BK4592","LU1914381329.SGD","BK4504","LU2112291526.USD","LU0234572021.USD","BK4533","LU1989763690.USD","BK4585","LU2089984988.USD","SG9999004303.SGD","ABT","LU2237957811.SGD","LU1989763427.SGD","LU0868494617.USD","SG9999002232.USD","LU1691799644.USD","IE00B2B36J28.USD","LU1721429402.USD","IE0009355771.USD","BK4568","IE00BFTCPJ56.SGD","LU2468319806.SGD","BK4588","LU1057294990.SGD","LU0170899867.USD"],"gpt_icon":0},{"id":"2552486424","title":"Abbott beats quarterly profit estimates on medical devices demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486424","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486424?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:30","pubTimestamp":1752751835,"startTime":"0","endTime":"0","summary":"Abbott beats quarterly profit estimates on medical devices demandJuly 17 (Reuters) - Abbott ABT.N beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its medical d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"98822823b65290e3eb63973caf6aa8eb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4N3TE0UR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IE00B3T34201.USD","LU2089283258.USD","BK4548","LU1061106388.HKD","LU2125909247.SGD","SGXZ23171101.USD","LU2089284900.SGD","LU1989763690.USD","LU0314106906.USD","LU0170899867.USD","IE00BMPRXN33.USD","LU1989763427.SGD","LU1506573853.SGD","LU1721429741.USD","LU1116320737.USD","LU2089984988.USD","BK4592","LU2125909593.SGD","LU1323610961.USD","LU1983299246.USD","BK4534","LU1057294990.SGD","IE0002141913.USD","LU1116320901.HKD","BK4566","LU1291159041.SGD","LU1571399168.USD","LU2271345857.HKD","LU0122379950.USD","ABT","IE00BFXG1179.USD","LU0211326755.USD","LU1989764664.SGD","BK4568","LU1989764748.USD","LU0976567544.SGD","LU0496365809.HKD","DXCM","LU1691799644.USD","BK4504","MDT","LU0265550359.USD","SG9999004303.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4533","LU2028103732.USD","IE00BMPRXR70.SGD","BK4581"],"gpt_icon":0},{"id":"2552696486","title":"Abbott Q2 REV $11.1 Bln VS Ibes Estimate $11.07 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2552696486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552696486?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:30","pubTimestamp":1752751809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nP8N3P10HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999002224.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","LU1721429741.USD","LU1914381329.SGD","LU0266013472.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU1061106388.HKD","BK4082","BK4592","LU0868494617.USD","LU1721429402.USD","BK4581","LU1023059063.AUD","BK4566","BK4568","IE00BJJMRZ35.SGD","LU2089984988.USD","BK4533","LU2133065610.SGD","LU2237957811.SGD","BK4588","IE0002141913.USD","LU1989763690.USD","ABT","LU1989763427.SGD","BK4585","LU1691799644.USD","LU2468319806.SGD","LU0122379950.USD","LU0234572021.USD","SG9999004303.SGD","LU2237957902.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4504","SG9999002232.USD","LU1057294990.SGD","IE0009355771.USD","SGXZ23171101.USD"],"gpt_icon":0},{"id":"2552486604","title":"Abbott: Plans to Build a New Manufacturing Facility in the U.S. State of Georgia by 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486604?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:30","pubTimestamp":1752751809,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nP8N3P10HD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4592","LU1989763690.USD","LU1721429402.USD","BK4566","LU1023059063.AUD","LU2112291526.USD","IE00B2B36J28.USD","LU1691799644.USD","LU1989763427.SGD","LU0170899867.USD","LU1061106388.HKD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","BK4585","BK4568","LU1914381329.SGD","LU1057294990.SGD","BK4533","IE00B4R5TH58.HKD","ABT","IE0009355771.USD","BK4581","IE00BJT1NW94.SGD","LU0868494617.USD","BK4588","LU2133065610.SGD","SG9999002224.SGD","IE00BFTCPJ56.SGD","LU2237957811.SGD","BK4504","BK4082","LU1721429741.USD","LU0266013472.USD","LU2089984988.USD","LU2468319806.SGD","SG9999002232.USD","SGXZ23171101.USD","SG9999004303.SGD","IE0002141913.USD","LU2237957902.USD"],"gpt_icon":0},{"id":"2552866074","title":"Abbott Q2 EPS USD 1.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2552866074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552866074?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:30","pubTimestamp":1752751807,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nPLXA29A0B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","LU1061106388.HKD","LU1914381329.SGD","SGXZ23171101.USD","LU1989763690.USD","LU2237957811.SGD","LU0170899867.USD","LU2237957902.USD","SG9999002232.USD","LU1989763427.SGD","LU1721429741.USD","BK4585","IE0009355771.USD","LU2089984988.USD","LU2468319806.SGD","LU2133065610.SGD","BK4592","BK4082","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU1057294990.SGD","BK4566","LU0122379950.USD","LU1721429402.USD","ABT","LU2112291526.USD","BK4568","LU1023059063.AUD","LU0868494617.USD","LU0266013472.USD","BK4504","LU1691799644.USD","SG9999004303.SGD","BK4588","IE00BJT1NW94.SGD","LU0234572021.USD","IE00BJJMRZ35.SGD","BK4533","SG9999002224.SGD","BK4581"],"gpt_icon":0},{"id":"2552648661","title":"Abbott Q2 Adjusted EPS USD 1.26 VS. Ibes Estimate USD 1.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2552648661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552648661?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:30","pubTimestamp":1752751807,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nPLXA29A0B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0170899867.USD","LU2237957902.USD","BK4568","SG9999002224.SGD","IE0009355771.USD","LU0122379950.USD","LU1989763427.SGD","LU1914381329.SGD","BK4588","IE00BJT1NW94.SGD","LU0266013472.USD","BK4585","IE00BJJMRZ35.SGD","BK4581","LU1061106388.HKD","LU1057294990.SGD","LU1721429741.USD","LU1023059063.AUD","LU2468319806.SGD","IE00B4R5TH58.HKD","SG9999002232.USD","BK4592","LU2133065610.SGD","LU0234572021.USD","BK4566","LU1989763690.USD","LU0868494617.USD","ABT","IE00BFTCPJ56.SGD","LU2237957811.SGD","IE0002141913.USD","IE00B2B36J28.USD","SG9999004303.SGD","BK4504","BK4533","LU1691799644.USD","BK4082","SGXZ23171101.USD","LU2089984988.USD","LU1721429402.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2552486621","title":"Abbott: Outlook FY2025 Organic Sales Growth, Excluding Covid-19 Testing Related Sales, to Be 7.5% to 8.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486621?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:30","pubTimestamp":1752751807,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nPLXA29A0B:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999004303.SGD","IE00BJT1NW94.SGD","LU2237957902.USD","SG9999002224.SGD","BK4568","BK4588","BK4581","LU0170899867.USD","LU1023059063.AUD","ABT","BK4533","IE00B4R5TH58.HKD","BK4592","LU0122379950.USD","SG9999002232.USD","LU0234572021.USD","IE0009355771.USD","LU1989763427.SGD","IE00B2B36J28.USD","LU1691799644.USD","SGXZ23171101.USD","LU0868494617.USD","LU2112291526.USD","LU0266013472.USD","LU2237957811.SGD","LU1721429402.USD","IE00BJJMRZ35.SGD","LU1989763690.USD","LU2089984988.USD","BK4585","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU1914381329.SGD","LU1721429741.USD","LU2133065610.SGD","BK4082","BK4566","BK4504","LU1061106388.HKD","LU2468319806.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2552486981","title":"Abbott Reports Second-Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486981?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:30","pubTimestamp":1752751807,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"98822823b65290e3eb63973caf6aa8eb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUA87QZLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4504","SG9999002232.USD","LU0868494617.USD","BK4581","LU1721429402.USD","BK4082","LU1023059063.AUD","BK4588","LU1721429741.USD","LU2112291526.USD","BK4592","BK4533","IE0002141913.USD","BK4568","LU2237957902.USD","LU0234572021.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1691799644.USD","LU1989763690.USD","SGXZ23171101.USD","IE00BJJMRZ35.SGD","BK4566","SG9999004303.SGD","LU2237957811.SGD","BK4585","LU0170899867.USD","LU1989763427.SGD","ABT","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE0009355771.USD","LU0122379950.USD","LU1914381329.SGD","LU2133065610.SGD","LU2089984988.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0266013472.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2552485994","title":"Bristol, Pfizer to sell blood thinner Eliquis directly to patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2552485994","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552485994?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:05","pubTimestamp":1752750352,"startTime":"0","endTime":"0","summary":"Bristol, Pfizer to sell blood thinner Eliquis directly to patients July 17  - US drugmakers Bristol Myers BMY.N and Pfizer PFE.N said on Thursday that they will make their blood thinner, Eliquis, available directly to cash-paying patients at discounted rate through a new program.    Eligible patients will be able to buy the drug directly through the Eliquis 360 Support program beginning September 8.   ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4N3TE0U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1894683348.USD","LU1670711040.USD","IE00BFXG1179.USD","LU1032466523.USD","LU1323610961.USD","SG9999001176.USD","BMY","LU1670711123.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU1066053197.SGD","LU1571399168.USD","LU0321505439.SGD","LU1868836591.USD","IE0009355771.USD","LU1868836914.USD","LU0225284248.USD","LU1057294990.SGD","BK4534","LU2125154935.USD","LU1894683264.USD","IE00BSNM7G36.USD","BK4533","BK4599","LU0061475181.USD","BK4568","LU0321505868.SGD","LU0096364046.USD","BK4581","LU1868836757.USD","SG9999002232.USD","BK4592","IE00BJJMRZ35.SGD","LU0234572021.USD","LU0456855351.SGD","LU0985481810.HKD","LU0114720955.EUR","LU1023059063.AUD","LU1868837300.USD","IE00BBT3K403.USD","LU1585245621.USD","BK4588","IE00BFTCPJ56.SGD","LU2360032135.SGD","LU0122379950.USD","PFE","LU1093756325.SGD","SG9999002224.SGD","LU2242652126.USD"],"gpt_icon":0},{"id":"2552485836","title":"Bristol-Myers Squibb Co - Eligible U.S. Patients Can Purchase Eliquis Directly From September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=2552485836","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552485836?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:59","pubTimestamp":1752749940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUABWVRQR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1291159041.SGD","LU1989771016.USD","LU0225771236.USD","LU1894683348.USD","BK4559","BK4568","LU2125154778.USD","IE00BLSP4452.SGD","IE00BSNM7G36.USD","LU0096364046.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1585245621.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","BK4533","LU1032466523.USD","SG9999013999.USD","IE00BFXG1179.USD","LU2360032135.SGD","SGXZ57979304.SGD","LU0306806265.USD","LU1571399168.USD","LU2133065610.SGD","LU2242652126.USD","LU2242646821.SGD","BK4007","IE00B19Z3581.USD","LU1868837300.USD","PFE","SG9999002232.USD","BK4581","LU1868836757.USD","IE0009355771.USD","LU1057294990.SGD","BK4588","LU0321505868.SGD","SG9999002224.SGD","LU0267386448.USD","LU1261432733.SGD","LU0237698245.USD","LU1670711040.USD","BK4585","BK4532","BK4592","IE00B2B36J28.USD","BMY","LU1074936037.SGD","LU1894683264.USD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2552025483","title":"Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (Apixaban) Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2552025483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552025483?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:59","pubTimestamp":1752749940,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUABWVRQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMY","SG9999002224.SGD","IE000M9KFDE8.USD","LU1571399168.USD","LU2242652126.USD","IE0009355771.USD","IE00BLSP4452.SGD","LU0225771236.USD","BK4532","LU0985481810.HKD","IE00BSNM7G36.USD","LU0237698245.USD","BK4581","BK4568","IE00B19Z3581.USD","LU0321505868.SGD","LU1670711040.USD","LU1868836757.USD","LU1032466523.USD","SG9999002232.USD","LU1585245621.USD","LU1868837300.USD","LU1291159041.SGD","LU1074936037.SGD","LU1894683264.USD","BK4007","BK4592","LU2360032135.SGD","IE00BFXG1179.USD","LU1989771016.USD","BK4588","BK4533","IE00B2B36J28.USD","LU2133065610.SGD","LU2242646821.SGD","LU0289739699.SGD","SG9999003800.SGD","SGXZ57979304.SGD","LU0096364046.USD","SG9999013999.USD","LU0306806265.USD","LU1057294990.SGD","BK4559","LU1261432733.SGD","LU0267386448.USD","LU1894683348.USD","BK4585","PFE","LU2125154778.USD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2552730483","title":"J&J : Leerink Partners Raises Target Price  to $171 From $153","url":"https://stock-news.laohu8.com/highlight/detail?id=2552730483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552730483?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:48","pubTimestamp":1752749331,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BVYPNV92.GBP","LU1066051225.USD","LU0345769631.USD","LU0320765646.SGD","BK4568","LU0289739699.SGD","LU1430594728.SGD","LU1935042991.SGD","LU2129689605.HKD","IE0009355771.USD","IE00B3T34201.USD","LU0114720955.EUR","LU2430703095.HKD","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","IE0034235303.USD","LU0098860793.USD","LU1244550221.USD","IE00BBT3K403.USD","LU0203345920.USD","BK4550","LU1023059063.AUD","LU2468319806.SGD","SG9999001440.SGD","SG9999002232.USD","BK4592","LU2133065610.SGD","LU1162221912.USD","LU0234572021.USD","LU1674673691.USD","JNJ","LU1732800096.USD","LU1267930813.SGD","BK4534","IE00BFTCPJ56.SGD","LU0345770993.USD","LU0912757837.SGD","LU1059921491.USD","LU1280957306.USD","LU0234570918.USD","IE0002270589.USD","LU0640476718.USD","LU0889566641.SGD","LU1066051811.HKD","LU1221951046.USD","LU2089984988.USD","LU0985320562.USD","LU1261432733.SGD","LU1244550577.SGD","LU2112291526.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":3,"totalSize":236,"code":"91000000","status":"200"}]}}